Dietary palmitoleic acid reprograms gut microbiota and improves biological therapy against colitis

References

• Fischbach MA, Segre JA. Signaling in host-associated microbial communities. Cell. 2016;164:1288–26. doi:10.1016/j.cell.2016.02.037.
   PubMed Web of Science ®Google Scholar
• Cani PD. Microbiota and metabolites in metabolic diseases. Nat Rev Endocrinol. 2019;15(2):69–70. doi:10.1038/s41574-018-0143-9.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19:55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• HSP de Souza, Fiocchi C, Iliopoulos D, de Souza HSP. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14(12):739–749. doi:10.1038/nrgastro.2017.110.
   PubMed Web of Science ®Google Scholar
• Makki K, Deehan EC, Walter J, Bäckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23(6):705–715. doi:10.1016/j.chom.2018.05.012.
   PubMed Web of Science ®Google Scholar
• Park S-Y, Rao C, Coyte KZ, Kuziel GA, Zhang Y, Huang W, Franzosa EA, Weng J-K, Huttenhower C, Rakoff-Nahoum S. Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite. Cell. 2022;185(3):513–29 e21. doi:10.1016/j.cell.2022.01.002.
   PubMed Web of Science ®Google Scholar
• Schirmer M, Garner A, Vlamakis H, Xavier RJ. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019;17:497–511. doi:10.1038/s41579-019-0213-6.
   PubMed Web of Science ®Google Scholar
• Nayar S, Morrison JK, Giri M, Gettler K, Chuang LS, Walker LA, Ko HM, Kenigsberg E, Kugathasan S, Merad M, et al. A myeloid–stromal niche and gp130 rescue in NOD2-driven Crohn’s disease. Nature. 2021;593(7858):275–281. doi:10.1038/s41586-021-03484-5.
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Brislawn CJ, Lamendella R, Vazquez-Baeza Y, Walters WA, Bramer LM, D’Amato M, Bonfiglio F, McDonald D, Gonzalez A, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017;2(5):17004. doi:10.1038/nmicrobiol.2017.4.
   PubMed Web of Science ®Google Scholar
• Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329–342. doi:10.1038/nri3661.
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–434. doi:10.1038/nature06005.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bhosle A, Bae S, McIver LJ, Pishchany G, Accorsi EK, Thompson KN, Arze C, Wang Y, Subramanian A, et al. Discovery of bioactive microbial gene products in inflammatory bowel disease. Nature. 2022;606(7915):754–760. doi:10.1038/s41586-022-04648-7.
   PubMed Web of Science ®Google Scholar
• Adolph TE, Meyer M, Schwärzler J, Mayr L, Grabherr F, Tilg H. The metabolic nature of inflammatory bowel diseases. Nat Rev Gastroenterol Hepatol. 2022;19(12):753–767. doi:10.1038/s41575-022-00658-y.
   PubMed Web of Science ®Google Scholar
• Aden K, Rehman A, Waschina S, Pan W-H, Walker A, Lucio M, Nunez AM, Bharti R, Zimmerman J, Bethge J, et al. Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases. Gastroenterol. 2019;157(5):1279. doi:10.1053/j.gastro.2019.07.025.
   PubMed Web of Science ®Google Scholar
• Caruso R, Lo BC, Nunez G. Host–microbiota interactions in inflammatory bowel disease. Nat Rev Immunol. 2020;20(7):411–426. doi:10.1038/s41577-019-0268-7.
   PubMed Web of Science ®Google Scholar
• Villablanca EJ, Selin K, Hedin CRH. Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression? Nat Rev Gastroenterol Hepatol. 2022;19(8):493–507. doi:10.1038/s41575-022-00604-y.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gharaibeh RZ, Newsome RC, Jobin C. Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer. Nat Cancer. 2020;1(7):723–734. doi:10.1038/s43018-020-0078-7.
   PubMedGoogle Scholar
• Zhuang X, Tian Z, Feng R, Li M, Li T, Zhou G, Qiu Y, Chen B, He Y, Chen M, et al. Fecal microbiota alterations associated with clinical and endoscopic response to infliximab therapy in Crohn’s disease. Inflamm Bowel Dis. 2020;26(11):1636–1647. doi:10.1093/ibd/izaa253.
   PubMed Web of Science ®Google Scholar
• Mills RH, Dulai PS, Vázquez-Baeza Y, Sauceda C, Daniel N, Gerner RR, Batachari LE, Malfavon M, Zhu Q, Weldon K, et al. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nature Microbiol. 2022;7(2):262–276. doi:10.1038/s41564-021-01050-3.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–106. doi:10.1136/gutjnl-2019-318484.
   PubMed Web of Science ®Google Scholar
• Allez M, Karmiris K, Louis E, Van Assche G, Ben-Horin S, Klein A, Van der Woude J, Baert F, Eliakim R, Katsanos K, et al. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. J Crohns Colitis. 2010;4(4):355–366. doi:10.1016/j.crohns.2010.04.004.
   PubMed Web of Science ®Google Scholar
• Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350(9):876–885. doi:10.1056/NEJMoa030815.
   PubMed Web of Science ®Google Scholar
• Battat R, Sandborn WJ . Advances in the comprehensive management of postoperative Crohn’s disease. Clin Gastroenterol Hepatol. 2022:20(7):1436–1449. doi:10.1016/j.cgh.2021.03.048.
   PubMed Web of Science ®Google Scholar
• Lee JWJ, Plichta D, Hogstrom L, Borren NZ, Lau H, Gregory SM, Tan W, Khalili H, Clish C, Vlamakis H, et al. Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe. 2021;29(8):1294–304.e4. doi:10.1016/j.chom.2021.06.019.
   PubMed Web of Science ®Google Scholar
• Ventin-Holmberg R, Eberl A, Saqib S, Korpela K, Virtanen S, Sipponen T, Salonen A, Saavalainen P, Nissilä E. Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease. J Crohns Colitis. 2021;15(6):1019–1031. doi:10.1093/ecco-jcc/jjaa252.
   PubMed Web of Science ®Google Scholar
• Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A, Orndorff PE. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn’s disease. Infect Immun. 1999;67(9):4499–4509. doi:10.1128/IAI.67.9.4499-4509.1999.
   PubMed Web of Science ®Google Scholar
• Engevik MA, Danhof HA, Ruan W, Engevik AC, Chang-Graham AL, Engevik KA, Shi Z, Zhao Y, Brand CK, Krystofiak ES, et al. Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. mBio. 2021;12(2):12. doi:10.1128/mBio.02706-20.
   Web of Science ®Google Scholar
• Yao Y, Ni H, Wang X, Xu Q, Zhang J, Jiang L, Wang B, Song S, Zhu X. A new biomarker of fecal bacteria for non-invasive diagnosis of colorectal cancer. Front Cell Infect Microbiol. 2021;11:744049. doi:10.3389/fcimb.2021.744049.
   PubMed Web of Science ®Google Scholar
• Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser H, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nature Microbiol. 2019;4(2):293–305. doi:10.1038/s41564-018-0306-4.
   PubMed Web of Science ®Google Scholar
• Nishida T, Miwa H, Shigematsu A, Yamamoto M, Iida M, Fujishima M. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut. 1987;28:1002–1007. doi:10.1136/gut.28.8.1002.
   PubMed Web of Science ®Google Scholar
• Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–450. doi:10.1038/nature12721.
   PubMed Web of Science ®Google Scholar
• Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795–803. doi:10.1016/S0016-5085(89)80079-4.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14. doi:10.1126/scitranslmed.3000322.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang G, Li G, Wang W, Ge Z, Yang Y, He X, Liu Z, Zhang Z, Mai Q, et al. Ifnar gene variants influence gut microbial production of palmitoleic acid and host immune responses to tuberculosis. Nat Metab. 2022;4(3):359–373. doi:10.1038/s42255-022-00547-3.
   PubMedGoogle Scholar
• Bae M, Cassilly CD, Liu X, Park S-M, Tusi BK, Chen X, Kwon J, Filipčík P, Bolze AS, Liu Z, et al. Akkermansia muciniphila phospholipid induces homeostatic immune responses. Nature. 2022;608(7921):168–173. doi:10.1038/s41586-022-04985-7.
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk AA, Zheng D, Elinav E. Diet–microbiota interactions and personalized nutrition. Nat Rev Microbiol. 2019;17(12):742–753. doi:10.1038/s41579-019-0256-8.
   PubMed Web of Science ®Google Scholar
• Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota–gut–brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461–478. doi:10.1038/s41575-019-0157-3.
   PubMed Web of Science ®Google Scholar
• Khan S, Waliullah S, Godfrey V, Khan MAW, Ramachandran RA, Cantarel BL, Behrendt C, Peng L, Hooper LV, Zaki H. Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice. Sci Transl Med. 2020;12(567):12. doi:10.1126/scitranslmed.aay6218.
   Web of Science ®Google Scholar
• Fornelos N, Franzosa EA, Bishai J, Annand JW, Oka A, Lloyd-Price J, Arthur TD, Garner A, Avila-Pacheco J, Haiser HJ, et al. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease. Nat Microbiol. 2020;5(3):486–497. doi:10.1038/s41564-019-0655-7.
   PubMed Web of Science ®Google Scholar
• Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D, Ramadhar TR, Lekbua A, et al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol. 2019;4(3):396–403. doi:10.1038/s41564-018-0307-3.
   PubMed Web of Science ®Google Scholar
• Hosomi K, Kiyono H, Kunisawa J. Fatty acid metabolism in the host and commensal bacteria for the control of intestinal immune responses and diseases. Gut Microbes. 2020;11(3):276–284. doi:10.1080/19490976.2019.1612662.
   PubMed Web of Science ®Google Scholar
• Korbecki J, Bajdak-Rusinek K. The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms. Inflamm Res. 2019;68(11):915–932. doi:10.1007/s00011-019-01273-5.
   PubMed Web of Science ®Google Scholar
• Ghezzal S, Postal BG, Quevrain E, Brot L, Seksik P, Leturque A, Thenet S, Carrière V. Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(2):158530. doi:10.1016/j.bbalip.2019.158530.
   PubMed Web of Science ®Google Scholar
• Kunisawa J, Hashimoto E, Inoue A, Nagasawa R, Suzuki Y, Ishikawa I, Shikata S, Arita M, Aoki J, Kiyono H. Regulation of intestinal IgA responses by dietary palmitic acid and its metabolism. J Immunol. 2014;193(4):1666–1671. doi:10.4049/jimmunol.1302944.
   PubMed Web of Science ®Google Scholar
• Schwärzler J, Mayr L, Vich Vila A, Grabherr F, Niederreiter L, Philipp M, Grander C, Meyer M, Jukic A, Tröger S, et al. PUFA-Induced metabolic enteritis as a fuel for Crohn’s disease. Gastroenterology. 2022;162(6):1690–1704. doi:10.1053/j.gastro.2022.01.004.
   PubMed Web of Science ®Google Scholar
• Ozogul Y, Duysak O, Ozogul F, Özkütük AS, Türeli C. Seasonal effects in the nutritional quality of the body structural tissue of cephalopods. Food Chem. 2008;108(3):847–852. doi:10.1016/j.foodchem.2007.11.048.
   PubMed Web of Science ®Google Scholar
• Yang B, Kallio HP. Fatty acid composition of lipids in sea buckthorn (Hippophaë rhamnoides L.) berries of different origins. J Agric Food Chem. 2001;49(4):1939–1947. doi:10.1021/jf001059s.
   PubMed Web of Science ®Google Scholar
• Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, Guo S-C, Du Y-Q, Chen L-N, Shen D-D, et al. Unsaturated bond recognition leads to biased signal in a fatty acid receptor. Science. 2023;380(6640):eadd6220. doi:10.1126/science.add6220.
   PubMed Web of Science ®Google Scholar
• Bernard A, Echinard B, Carlier H. Differential intestinal absorption of two fatty acid isomers: elaidic and oleic acids. Am J Physiol. 1987;253(6):G751–9. doi:10.1152/ajpgi.1987.253.6.G751.
   PubMedGoogle Scholar
• Kolouchová I, Sigler K, Schreiberová O, Masák J, Řezanka T. New yeast-based approaches in production of palmitoleic acid. Bioresour Technol. 2015;192:726–734. doi:10.1016/j.biortech.2015.06.048.
   PubMed Web of Science ®Google Scholar
• D’Haens GR, van Deventer S. 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future. Gut. 2021;70:1396–1405. doi:10.1136/gutjnl-2019-320022.
   PubMed Web of Science ®Google Scholar
• Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastro Hepat. 2020;17(4):223–237. doi:10.1038/s41575-019-0258-z.
   PubMed Web of Science ®Google Scholar
• Friedrich M, Pohin M, Jackson MA, Korsunsky I, Bullers SJ, Rue-Albrecht K, Christoforidou Z, Sathananthan D, Thomas T, Ravindran R, et al. IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. Nat Med. 2021;27(11):1970–1981. doi:10.1038/s41591-021-01520-5.
   PubMed Web of Science ®Google Scholar
• Ding NS, McDonald JAK, Perdones-Montero A, Rees DN, Adegbola SO, Misra R, Hendy P, Penez L, Marchesi JR, Holmes E, et al. Metabonomics and the gut microbiome associated with primary response to anti-TNF therapy in Crohn’s disease. J Crohns Colitis. 2020;14(8):1090–1102. doi:10.1093/ecco-jcc/jjaa039.
   PubMed Web of Science ®Google Scholar
• Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microb. 2007;73(16):5261–5267. doi:10.1128/AEM.00062-07.
   PubMed Web of Science ®Google Scholar
• Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238–249.
   PubMed Web of Science ®Google Scholar
• Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12(7):1295–1309. doi:10.1038/nprot.2017.044.
   PubMed Web of Science ®Google Scholar
• Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989;96:29–36. doi:10.1016/0016-5085(89)90760-9.
   PubMed Web of Science ®Google Scholar
• Ameho CK, Adjei AA, Harrison EK, Takeshita K, Morioka T, Arakaki Y, Ito E, Suzuki I, Kulkarni AD, Kawajiri A, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis. Gut. 1997;41(4):487–493. doi:10.1136/gut.41.4.487.
   PubMed Web of Science ®Google Scholar
• Yang F, Yang Y, Chen L, Zhang Z, Liu L, Zhang C, Mai Q, Chen Y, Chen Z, Lin T, et al. The gut microbiota mediates protective immunity against tuberculosis via modulation of lncRNA. Gut Microbes. 2022;14(1):2029997. doi:10.1080/19490976.2022.2029997.
   PubMed Web of Science ®Google Scholar